Neonatal fatty acid profiles are correlated with infant growth measures at 6 months

P F O'Tierney-Ginn1, D Davina2, M Gillingham3

  • 11Department of Reproductive Biology,Center for Reproductive Health,Case Western Reserve University,Cleveland,OH,USA.

Insights

Infant weight gain and fat deposition are linked to neonatal fatty acid profiles. Low levels of n-3 long chain polyunsaturated fatty acids (LCPUFA) at birth correlate with increased adiposity and altered infant growth trajectories.

Area of Science:

  • Perinatal nutrition and infant development
  • Maternal-fetal lipid metabolism
  • Human growth and body composition

Background:

  • Rapid infant weight gain and low neonatal n-3 long chain polyunsaturated fatty acids (LCPUFA) are linked to later-life adiposity.
  • The role of placental LCPUFA transfer in infant growth is not well understood.
  • Maternal factors and placental function may influence offspring growth patterns.

Purpose of the Study:

  • To investigate the relationships between maternal phenotype, placental fatty acid transporter expression, and infant growth over the first six months.
  • To determine how neonatal fatty acid profiles affect infant body composition, including fat and lean mass deposition.

Main Methods:

  • Collection of placental tissue and cord blood at term delivery from uncomplicated pregnancies.
  • Measurement of offspring body composition (BMI z-scores, skinfold thickness, arm muscle area) at birth and at 6 months.
  • Analysis of correlations between neonatal LCPUFA and saturated fatty acid levels, placental fatty acid transporter gene expression, and infant growth parameters.

Main Results:

  • High birth skinfold thickness and increased BMI z-scores in infancy were associated with lower neonatal n-3 LCPUFA and higher saturated fatty acid plasma levels.
  • Infant skinfold growth correlated with placental fatty acid transporter gene expression.
  • Changes in BMI z-score during the first six months were linked to arm muscle area growth (lean mass) but not skinfold thickness growth.

Conclusions:

  • Neonatal fatty acid profiles, particularly n-3 LCPUFA status, may significantly influence infant growth trajectories and the deposition of fat and lean mass.
  • Placental lipid handling appears to play a role in infant fat deposition.
  • Early life nutritional status and placental function are critical determinants of infant body composition.

Related Concept Videos

Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.5K
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
303
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
503